Investegate |MaxCyte, Inc. Announcements | MaxCyte, Inc.: Grant of Options
Investegate announcements from MaxCyte, Inc., Grant of Options
Source: investegate.co.uk
Page 4 - Stan Erck News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Stan Erck. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Stan Erck Today - Breaking & Trending Today
Hogan Tours Future Site of Novavax Global HQ in Gaithersburg; 500 Jobs to be Added
Gov. Larry Hogan and other leaders visited Gaithersburg on Thursday to tour the site of Novavax’s future global headquarters. More than a year ago, Novavax began developing a promising COVID-19 vaccine. Stan Erck, the president and CEO of Novavax, said that Novavax is completing phase three of vaccine trials and results have been promising. “I’m happy to […]
Source: mymcmedia.org
Novavax celebrates future expanded Gaithersburg headquarters
The growing biotech sector in Montgomery County, Maryland, will be getting bigger: Novavax on Thursday celebrated what will be an enormous new headquarters complex in Gaithersburg.
Source: wtop.com
Hogan tours new Novavax Global Headquarters in Montgomery County
WBAL Radio 1090 AM - Hogan tours new Novavax Global Headquarters in Montgomery County
Source: wbal.com
Onshore mRNA manufacturing gets budget shot in the arm
CSL subsidiary Seqirus operates Australia’s only onshore influenza vaccine manufacturing facility. Related Quotes Advertisement The company said COVID-19 has accelerated the technology from a promising science to a viable technology platform that can be produced at industrial scale. Seqirus senior vice president for research and development Russell Basser said research for next-generation mRNA, known as self-amplifying mRNA, for influenza had seen promising pre-clinical results. Human clinical trials are due to commence next year. “CSL has a 100-year track record as a proven pandemic part...
Source: afr.com